ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Michael Boyd Named New DTP Director; Saunders Retires; Michael Friedman New Chief Of CIB

October 7, 1983

NCAB Votes To ‘Keep Alive’ Concept For Stage 2 Breast Cancer Fat Trial

February 14, 1986

Oncology Practice Group Leaves Allegheny For Former Rival UPCI; Will NSABP Follow?

June 30, 2000

Celecoxib Effective To Prevent Colon Adenomas, Study Finds

April 25, 2008

Diane Fink Accepts VP Job With ACS

April 3, 1981

Cancer Researchers Share 2001 Nobel Prize For Cell Cycle, Chromosome Discoveries.

October 12, 2001